drugset / Trial / NCT01656759

Use of a Novel Fibrin Sealant in Total Knee Arthroplasty

NCT01656759 ↗

Phase 2/3 Completed 73 enrolled Rush University Medical Center
RandomizedSingle-groupDouble-blindTreatment

Summary

Applying a fibrin spray, after knee device implantation, will help in reducing patient blood loss and decrease the drop in both hemoglobin and hematocrit levels. Also, with decreased blood loss there should be a reduced need for blood transfusions.

Timeline

Start
2012-05
Primary completion
2014-12
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Evicel Fibrin Spray Protein / enzyme biologic 10 ml Topical

Indications